Merck KGaA (MKGAY) Given Average Recommendation of "Buy" by Analysts


Merck KGaA has been given a consensus rating of "Buy" by the twelve brokerages that are presently covering the firm. Six investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company.



from Biotech News